Table of Contents

June 2007, Volume 14, Number 2

Reviews

    • Richard J Santen,
    • Norman F Boyd,
    • Rowan T Chlebowski,
    • Steven Cummings,
    • Jack Cuzick,
    • Mitch Dowsett,
    • Douglas Easton,
    • John F Forbes,
    • Tim Key,
    • Susan E Hankinson,
    • Anthony Howell,
    • and James Ingle

    Critical assessment of new risk factors for breast cancer: considerations for development of an improved risk prediction model

    Endocr Relat Cancer 14 (2) 169-187, doi:10.1677/ERC-06-0045
    • Linda Vona-Davis and
    • David P Rose

    Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression

    Endocr Relat Cancer 14 (2) 189-206, doi:10.1677/ERC-06-0068
    • Matthew H Kulke

    Gastrointestinal neuroendocrine tumors: a role for targeted therapies?

    Endocr Relat Cancer 14 (2) 207-219, doi:10.1677/ERC-06-0061
    • Eduardo Vilar,
    • Ramón Salazar,
    • Jose Pérez-García,
    • Javier Cortes,
    • Kjell Öberg,
    • and Josep Tabernero

    Chemotherapy and role of the proliferation marker Ki-67 in digestive neuroendocrine tumors

    Endocr Relat Cancer 14 (2) 221-232, doi:10.1677/ERC-06-0074
    • M J Grimshaw

    Endothelins and hypoxia-inducible factor in cancer

    Endocr Relat Cancer 14 (2) 233-244, doi:10.1677/ERC-07-0057

Research

    • R Engers,
    • S Ziegler,
    • M Mueller,
    • A Walter,
    • R Willers,
    • and H E Gabbert

    Prognostic relevance of increased Rac GTPase expression in prostate carcinomas

    Endocr Relat Cancer 14 (2) 245-256, doi:10.1677/ERC-06-0036
    • Fabiana Cillo,
    • Magda de Eguileor,
    • Fulvio Gandolfi,
    • and Tiziana A L Brevini

    Aroclor-1254 affects mRNA polyadenylation, translational activation, cell morphology, and DNA integrity of rat primary prostate cells

    Endocr Relat Cancer 14 (2) 257-266, doi:10.1677/ERC-06-0081
    • Annika Vaclavicek,
    • Justo Lorenzo Bermejo,
    • Rita K Schmutzler,
    • Christian Sutter,
    • Barbara Wappenschmidt,
    • Alfons Meindl,
    • Marion Kiechle,
    • Norbert Arnold,
    • Bernhard H F Weber,
    • Dieter Niederacher,
    • Barbara Burwinkel,
    • Claus R Bartram,
    • Kari Hemminki,
    • and Asta Försti

    Polymorphisms in the Janus kinase 2 (JAK)/signal transducer and activator of transcription (STAT) genes: putative association of the STAT gene region with familial breast cancer

    Endocr Relat Cancer 14 (2) 267-277, doi:10.1677/ERC-06-0077
    • Takashi Suzuki,
    • Akio Inoue,
    • Yasuhiro Miki,
    • Takuya Moriya,
    • Jun-ichi Akahira,
    • Takanori Ishida,
    • Hisashi Hirakawa,
    • Yuri Yamaguchi,
    • Shin-ichi Hayashi,
    • and Hironobu Sasano

    Early growth responsive gene 3 in human breast carcinoma: a regulator of estrogen-meditated invasion and a potent prognostic factor

    Endocr Relat Cancer 14 (2) 279-292, doi:10.1677/ERC-06-0005
    • Hoo Kyun Choi,
    • Jin Won Yang,
    • Sang Hee Roh,
    • Chang Yeob Han,
    • and Keon Wook Kang

    Induction of multidrug resistance associated protein 2 in tamoxifen-resistant breast cancer cells

    Endocr Relat Cancer 14 (2) 293-303, doi:10.1677/ERC-06-0016
    • Manali Mody,
    • Nachiket Dharker,
    • Mark Bloomston,
    • Pei-Shan Wang,
    • Fu-Sheng Chou,
    • Theodore S Glickman,
    • Timothy McCaffrey,
    • Zhaoqing Yang,
    • Anne Pumfery,
    • Daniel Lee,
    • Matthew D Ringel,
    • and Joseph J Pinzone

    Rosiglitazone sensitizes MDA-MB-231 breast cancer cells to anti-tumour effects of tumour necrosis factor-α, CH11 and CYC202

    Endocr Relat Cancer 14 (2) 305-315, doi:10.1677/ERC-06-0003
    • Daniela Gallo,
    • Elisabetta Mantuano,
    • Manuela Fabrizi,
    • Cristiano Ferlini,
    • Simona Mozzetti,
    • Ilaria De Stefano,
    • and Giovanni Scambia

    Effects of a phytoestrogen-containing soy extract on the growth-inhibitory activity of ICI 182 780 in an experimental model of estrogen-dependent breast cancer

    Endocr Relat Cancer 14 (2) 317-324, doi:10.1677/ERC-06-0054
    • Frauke Döll,
    • Josef Pfeilschifter,
    • and Andrea Huwiler

    Prolactin upregulates sphingosine kinase-1 expression and activity in the human breast cancer cell line MCF7 and triggers enhanced proliferation and migration

    Endocr Relat Cancer 14 (2) 325-335, doi:10.1677/ERC-06-0050
    • Suzanne M Johnson,
    • Manijeh Maleki-Dizaji,
    • Jerry A Styles,
    • and Ian N H White

    Ishikawa cells exhibit differential gene expression profiles in response to oestradiol or 4-hydroxytamoxifen

    Endocr Relat Cancer 14 (2) 337-350, doi:10.1677/ERC-06-0085
    • Sumie Kato,
    • Anil Sadarangani,
    • Soledad Lange,
    • Manuel Villalón,
    • Jorge Brañes,
    • Jan J Brosens,
    • Gareth I Owen,
    • and Mauricio Cuello

    The oestrogen metabolite 2-methoxyoestradiol alone or in combination with tumour necrosis factor-related apoptosis-inducing ligand mediates apoptosis in cancerous but not healthy cells of the human endometrium

    Endocr Relat Cancer 14 (2) 351-368, doi:10.1677/ERC-07-0008
    • Ann M Dorward,
    • Kathryn L Shultz,
    • and Wesley G Beamer

    LH analog and dietary isoflavones support ovarian granulosa cell tumor development in a spontaneous mouse model

    Endocr Relat Cancer 14 (2) 369-379, doi:10.1677/erc.1.01232
    • Theodoros Foukakis,
    • Arief Gusnanto,
    • Amy YM Au,
    • Anders Höög,
    • Weng-Onn Lui,
    • Catharina Larsson,
    • Göran Wallin,
    • and Jan Zedenius

    A PCR-based expression signature of malignancy in follicular thyroid tumors

    Endocr Relat Cancer 14 (2) 381-391, doi:10.1677/ERC-06-0023
    • Uberta Verga,
    • Stefano Ferrero,
    • Leonardo Vicentini,
    • Tatiana Brambilla,
    • Valentina Cirello,
    • Marina Muzza,
    • Paolo Beck-Peccoz,
    • and Laura Fugazzola

    Histopathological and molecular studies in patients with goiter and hypercalcitoninemia: reactive or neoplastic C-cell hyperplasia?

    Endocr Relat Cancer 14 (2) 393-403, doi:10.1677/ERC-06-0053
    • Gennaro Chiappetta,
    • Carmela De Marco,
    • Alfina Quintiero,
    • Daniela Califano,
    • Simona Gherardi,
    • Donatella Malanga,
    • Marianna Scrima,
    • Cristina Montero-Conde,
    • Letizia Cito,
    • Mario Monaco,
    • Maria Letizia Motti,
    • Rosa Pasquinelli,
    • Valter Agosti,
    • Mercedes Robledo,
    • Alfredo Fusco,
    • and Giuseppe Viglietto

    Overexpression of the S-phase kinase-associated protein 2 in thyroid cancer

    Endocr Relat Cancer 14 (2) 405-420, doi:10.1677/ERC-06-0030
    • Douangsone D Vadysirisack,
    • Anjli Venkateswaran,
    • Zhaoxia Zhang,
    • and Sissy M Jhiang

    MEK signaling modulates sodium iodide symporter at multiple levels and in a paradoxical manner

    Endocr Relat Cancer 14 (2) 421-432, doi:10.1677/erc.1.01263
    • Viktor Johanson,
    • Håkan Ahlman,
    • Peter Bernhardt,
    • Svante Jansson,
    • Lars Kölby,
    • Fredrik Persson,
    • Göran Stenman,
    • Christina Swärd,
    • Bo Wängberg,
    • Mats Stridsberg,
    • and Ola Nilsson

    A transplantable human medullary thyroid carcinoma as a model for RET tyrosine kinase-driven tumorigenesis

    Endocr Relat Cancer 14 (2) 433-444, doi:10.1677/ERC-06-0033
    • Raffaele Ciampi,
    • Thomas J Giordano,
    • Kathryn Wikenheiser-Brokamp,
    • Ronald J Koenig,
    • and Yuri E Nikiforov

    HOOK3-RET: a novel type of RET/PTC rearrangement in papillary thyroid carcinoma

    Endocr Relat Cancer 14 (2) 445-452, doi:10.1677/ERC-07-0039
    • Esther Korpershoek,
    • Bart-Jeroen Petri,
    • Francien H van Nederveen,
    • Winand N M Dinjens,
    • Albert A Verhofstad,
    • Wouter W de Herder,
    • Sonja Schmid,
    • Aurel Perren,
    • Paul Komminoth,
    • and Ronald R de Krijger

    Candidate gene mutation analysis in bilateral adrenal pheochromocytoma and sympathetic paraganglioma

    Endocr Relat Cancer 14 (2) 453-462, doi:10.1677/ERC-06-0044
    • Frederieke M Brouwers,
    • Sven Gläsker,
    • Amanda F Nave,
    • Alexander O Vortmeyer,
    • Irina Lubensky,
    • Steven Huang,
    • Mones S Abu-Asab,
    • Graeme Eisenhofer,
    • Robert J Weil,
    • Deric M Park,
    • W Marston Linehan,
    • Karel Pacak,
    • and Zhengping Zhuang

    Proteomic profiling of von Hippel–Lindau syndrome and multiple endocrine neoplasia type 2 pheochromocytomas reveals different expression of chromogranin B

    Endocr Relat Cancer 14 (2) 463-471, doi:10.1677/ERC-06-0038
    • Maria Chiara Zatelli,
    • Mirella Torta,
    • Antonette Leon,
    • Maria Rosaria Ambrosio,
    • Massimo Gion,
    • Paola Tomassetti,
    • Filippo De Braud,
    • Gianfranco Delle Fave,
    • Luigi Dogliotti,
    • Ettore C degli Uberti,
    • and On behalf of the Italian CromaNet Working Group
    • , On behalf of the Italian CromaNet Working Group

    Chromogranin A as a marker of neuroendocrine neoplasia: an Italian Multicenter Study

    Endocr Relat Cancer 14 (2) 473-482, doi:10.1677/ERC-07-0001
    • Yasuhiko Nagano,
    • Do Ha Kim,
    • Li Zhang,
    • Jill A White,
    • James C Yao,
    • Stanley R Hamilton,
    • and Asif Rashid

    Allelic alterations in pancreatic endocrine tumors identified by genome-wide single nucleotide polymorphism analysis

    Endocr Relat Cancer 14 (2) 483-492, doi:10.1677/ERC-06-0090
    • F Cetani,
    • E Pardi,
    • E Ambrogini,
    • P Viacava,
    • S Borsari,
    • M Lemmi,
    • L Cianferotti,
    • P Miccoli,
    • A Pinchera,
    • A Arnold,
    • and C Marcocci

    Different somatic alterations of the HRPT2 gene in a patient with recurrent sporadic primary hyperparathyroidism carrying an HRPT2 germline mutation

    Endocr Relat Cancer 14 (2) 493-499, doi:10.1677/ERC-06-0092
    • C C Juhlin,
    • A Villablanca,
    • K Sandelin,
    • F Haglund,
    • J Nordenström,
    • L Forsberg,
    • R Bränström,
    • T Obara,
    • A Arnold,
    • C Larsson,
    • and A Höög

    Parafibromin immunoreactivity: its use as an additional diagnostic marker for parathyroid tumor classification

    Endocr Relat Cancer 14 (2) 501-512, doi:10.1677/ERC-07-0021
    • Chiachen Chen,
    • Yuan-Ching Chang,
    • Chien-Liang Liu,
    • Tsang-Pai Liu,
    • King-Jen Chang,
    • and Ing-Cherng Guo

    Leptin induces proliferation and anti-apoptosis in human hepatocarcinoma cells by up-regulating cyclin D1 and down-regulating Bax via a Janus kinase 2-linked pathway

    Endocr Relat Cancer 14 (2) 513-529, doi:10.1677/ERC-06-0027
|

This Issue

June 2007; 14 (2)
Cover
  1. Reviews
  2. Research

Find articles in this issue containing these words:

New Articles: issue in progress

  1. December 2017, 24 (12)
  1. Current Issue
  1. Alert me to new issues of Endocrine-Related Cancer

Most